Pfizer
Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
13 Feb 2025
TALZENNA + XTANDI is the first PARP inhibitor plus ARPI combination to demonstrate statistically significant and clinically meaningful improvement in overall survival (OS) in patients with metastatic
U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
12 Feb 2025
Approval is based on positive data from the Phase 3 ECHELON-3 trial, which demonstrated ADCETRIS regimen reduced the risk of death by 37%, a statistically significant, clinically meaningful improvemen
Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
11 Feb 2025
Enfortumab vedotin plus pembrolizumab continues to demonstrate superior efficacy versus chemotherapy in a broad population, reinforcing the combination as standard of care in first-line treatment of l
Pfizer’s BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial
03 Feb 2025
BRAFTOVI in combination with cetuximab and mFOLFOX6 showed statistically significant and clinically meaningful improvement in progression-free survival and overall survival in patients with metastatic
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
31 Jan 2025
More than 20 abstracts span Pfizer’s leading genitourinary cancer portfolio of approved standards of care and growing pipeline across prostate and bladder cancers Detailed overall survival (OS) result
Pfizer’s BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
31 Jan 2025
Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial show objective response rate of 61% with Pfizer’s BRAFTOVI combination regimen compared to 40% with invest
Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
10 Jan 2025
C linically meaningful and statistically significant results are the first pivotal Phase 3 data for sasanlimab, a subcutaneously administered PD-1 inhibitor If approved, sasanlimab would be the first
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
21 Dec 2024
BRAFTOVI in combination with cetuximab and mFOLFOX6 is the first and only combination regimen with targeted therapy approved for use as early as first-line for patients with metastatic colorectal canc
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts
19 Dec 2024
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EST on Tuesday, February 4, 2025. The purpo
Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance
17 Dec 2024
Full-Year 2025 Revenue Guidance (1) Range of $61.0 to $64.0 Billion Full-Year 2025 Adjusted (2) Diluted EPS Guidance Range of $2.80 to $3.00 Expect Full-Year 2025 Adjusted (2) Diluted EPS Operational
Featured
Company story – Quaker Oats
By Kiron Kasbekar | 08 Mar 2024
Quaker Oats is a company whose products I remember from my childhood days. Years before a foreign exchange crisis caused the Indian government to impose curbs on consumer product imports, we used to see a host of foreign brands in the Indian market. Including Quaker Oats, which I remember eating when I was a child, and which has been available for the past two decades or more.
How Quaker Oats grabbed customers’ attention
By Kiron Kasbekar | 07 Mar 2024
Quaker Oats, the American food products giant that was created in 1901 through the merger of many older oat millers, and was acquired by a bigger foods giant, Pepsi, in 2001, has been an innovative company. One example of its innovativeness shows in its packaging – the cereal box it launched in 1915.
Company story – Cunard Line
By Kiron Kasbekar | 12 Jan 2024
The Cunard Line started its life in Glasgow in 1839 as the British and North American Royal Mail Steam-Packet Company when Samuel Cunard was awarded the first British transatlantic steamship mail contract.
Samuel Slater – textile tycoon or traitor?
By Kiron Kasbekar | 26 Dec 2023
Samuel Slater is a name that holds significant importance in the annals of American industrial history. Often referred to as the ‘Father of the American Factory System’, Slater's contributions played a pivotal role in shaping the nation’s industrial landscape.
Underwood Typewriter Company – an icon of the past
By Kiron Kasbekar | 21 Dec 2023
You’ve probably never heard of Underwood typewriters. For the company folded up in 1963 – 60 years ago. You may not even have seen and handled a typewriter, unless someone in your family owned one.
The rise and fall of Chrysler
By Kiron Kasbekar | 16 Dec 2023
A century ago, the American automobile industry was more crowded than a vegetable market on a Sunday morning, with such a wide variety of stuff on sale that buyers were spoilt for choice. Buyers could pick and choose, bargain, pay up and drive out with the newly purchased vehicle.
TRW – the tide turned
By Kiron Kasbekar | 13 Dec 2023
There used to be an American company called Thompson Ramo Wooldridge Inc. This company, which was a global supplier of automotive systems, modules, and components to car and truck manufacturers, started small, as most companies do. Then, as the automotive industry grew bigger, so did TRW.
The rise and fall of Nokia
By Aniket Gupta | 07 Dec 2023
My interest is stories about dominant companies that failed all of a sudden. These companies were once etched into people’s minds but have since become a symbol of nostalgia. One such company, which was the biggest in its industry before it failed catastrophically, is Nokia.
Yahoo!: The first king of the internet
By Aniket Gupta | 01 Dec 2023
The year is 1994. You go to the internet to search for a particular website, but there is no Google that could be used to search your desired website. What do you do? The answer is that you use Yahoo.
.jpg)
